Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 1258 Specimen Handling 864 Carboplatin 824 Magnetic Resonance Spectroscopy 806 Cyclophosphamide 798 Cisplatin 719 Nivolumab 660 Paclitaxel 635 Gemcitabine 570 Radiotherapy 570 Biopsy 526 Bevacizumab 467 Dexamethasone 441 fludarabine 403 Docetaxel 375 venetoclax 369 Oxaliplatin 363 Capecitabine 355 Fluorouracil 354 atezolizumab 337 Rituximab 333 durvalumab 332 Doxorubicin 316 Pemetrexed 306 Radiosurgery 304 Drug Therapy 300 Ipilimumab 296 Standard of Care 288 Etoposide 283 Radiation 277

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Toremifene × 1 year × Clear all

NCT05472792 2026-05-26

CAMERAN

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡